Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 – Clinical Trial Not Allowed)

0
1

Funding Opportunity ID:334980
Opportunity Number:RFA-DA-22-018
Opportunity Title:Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 – Clinical Trial Not Allowed)
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Grant
Category of Funding Activity:Education
Health
Category Explanation:
CFDA Number(s):93.279
Eligible Applicants:Small businesses
Additional Information on Eligibility:Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Agency Code:HHS-NIH11
Agency Name:Department of Health and Human Services
National Institutes of Health
Posted Date:Jul 29, 2021
Close Date:Feb 18, 2022
Last Updated Date:Jul 29, 2021
Award Ceiling:$0
Award Floor:$0
Estimated Total Program Funding:
Expected Number of Awards:
Description:This Funding Opportunity Announcement (FOA) solicits grant applications from small business concerns (SBCs) to continue research projects with robustly validated targets for Substance Use Disorders (SUDs). This FOA will provide funding for projects entering at either assay development (AD), lead identification (LI), lead optimization (LO), or preclinical development (PCD) stages to allow for the ultimate goal of successfully completing Investigational New Drug-enabling activities.
Version:1





Visit the Official Webpage For More Details on Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 – Clinical Trial Not Allowed)

LEAVE A REPLY

Please enter your comment!
Please enter your name here